Geron Corp at Needham Healthcare Conference (Virtual) Transcript

Apr 13, 2022 / 07:45PM GMT
Gil Blum - Needham & Company, LLC - Analyst

Good afternoon and welcome to day three of the Needham & Company healthcare conference. My name is Gil Blum, and I am a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today Geron management team. (Conference Instructions)

And with that, Chip, you have the stage.

Chip Scarlett - Geron Corporation - Chairman, President, & CEO

Thanks a lot, Gil, and good afternoon, everyone. I am Chip Scarlett; I'm the Chairman and CEO of Geron Corporation. I'm delighted to be here representing my colleagues at Geron. And I would like to thank the organizers and Gil, in particular, for inviting me to speak today.

Next slide, please. During the course of this presentation and question-and-answer session, there will be forward-looking statements regarding future events, performance, plans, expectations, and other projections, including those relating to the therapeutic potential of and potential regulatory approval of imetelstat, anticipated clinical and commercial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot